POLG — DNA Polymerase Subunit Gamma

Migration, Crosslink

📖

POLG — DNA Polymerase Subunit Gamma

active

wiki page Created: 2026-04-02T07:19:26 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-polg

📖 Wiki Page

gene2250 wordssynced 2026-04-02

POLG — DNA Polymerase Subunit Gamma

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">polg</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>POLG</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DNA Polymerase Subunit Gamma</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q25</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5428</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>174763</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000140521</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9UQF2</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>DNA polymerase, family A</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alpers-Huttenlocher Syndrome, PEO, Parkinson's Disease, Alzheimer's Disease, Mitochondrial DNA Depletion Syndrome</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">Polymerase domain</td>
<td>aa 1-600</td>
</tr>
<tr>
<td class="label">Linker region</td>
<td>aa 600-800</td>
</tr>
<tr>
<td class="label">Exonuclease domain</td>
<td>aa 800-1100</td>
</tr>
<tr>
<td class="label">C-terminal domain</td>
<td>aa 1100-1239</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">TWNK</td>
<td>DNA helicase, unwinds mtDNA</td>
</tr>
<tr>
<t

...

POLG — DNA Polymerase Subunit Gamma

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">polg</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>POLG</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DNA Polymerase Subunit Gamma</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q25</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5428</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>174763</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000140521</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9UQF2</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>DNA polymerase, family A</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alpers-Huttenlocher Syndrome, PEO, Parkinson's Disease, Alzheimer's Disease, Mitochondrial DNA Depletion Syndrome</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">Polymerase domain</td>
<td>aa 1-600</td>
</tr>
<tr>
<td class="label">Linker region</td>
<td>aa 600-800</td>
</tr>
<tr>
<td class="label">Exonuclease domain</td>
<td>aa 800-1100</td>
</tr>
<tr>
<td class="label">C-terminal domain</td>
<td>aa 1100-1239</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">TWNK</td>
<td>DNA helicase, unwinds mtDNA</td>
</tr>
<tr>
<td class="label">mtSSB</td>
<td>Single-stranded DNA binding</td>
</tr>
<tr>
<td class="label">POLRMT</td>
<td>RNA polymerase, primers</td>
</tr>
<tr>
<td class="label">TFAM</td>
<td>Transcription factor, mtDNA packaging</td>
</tr>
<tr>
<td class="label">TP</td>
<td>Mitochondrial RNA primer</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Tissues Affected</td>
</tr>
<tr>
<td class="label">MTDPS1</td>
<td>Muscle</td>
</tr>
<tr>
<td class="label">MTDPS4</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">MTDPS7</td>
<td>Liver</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
<td>High</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>High</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
</table>

Pathway Diagram

Mermaid diagram (expand to render)

Introduction

POLG (DNA Polymerase Subunit Gamma) encodes the catalytic subunit of the mitochondrial DNA polymerase, which is the sole DNA polymerase responsible for replication and maintenance of the mitochondrial genome. This 1239-amino acid protein is essential for the propagation of mitochondrial DNA (mtDNA) and contains both polymerase activity for DNA synthesis and 3'-5' exonuclease activity for proofreading. POLG is one of the most commonly mutated genes in mitochondrial disease, with over 300 pathogenic variants identified that cause a spectrum of disorders ranging from Alpers-Huttenlocher syndrome (a severe childhood encephalopathy) to progressive external ophthalmoplegia (PEO) and late-onset parkinsonism. [@polg_mtdna_2024]

The mitochondrial genome is a compact, circular DNA molecule encoding 13 essential components of the oxidative phosphorylation (OXPHOS) system, along with the rRNA and tRNA genes required for their translation. POLG maintains this genome throughout life, and its proper function is critical for cellular energy production, particularly in tissues with high metabolic demands such as [neurons](/entities/neurons), [cardiac muscle](/cell-types/cardiac-muscle), and skeletal muscle. The central role of POLG in mtDNA maintenance links it to the pathogenesis of multiple neurodegenerative diseases, including [Parkinson's disease](/diseases/parkinsons-disease), [Alzheimer's disease](/diseases/alzheimers-disease), and age-related neurodegeneration. [@polg_neurodegeneration_2021]

Overview

Function

POLG is the catalytic engine of the mitochondrial DNA replication machinery, one of the essential components of the mtDNA replisome that includes the helicase TWNK (Twinkle), the single-stranded DNA-binding protein (mtSSB), and the mitochondrial RNA polymerase (POLRMT). POLG synthesizes both the leading and lagging strands of the circular mtDNA molecule in a processive manner, and its intrinsic proofreading activity ensures high fidelity of mtDNA replication. The enzyme can also participate in base excision repair (BER) of damaged mtDNA, making it important for mtDNA repair and genome stability. [@polg_replication_2022]

Polymerase Activity

The primary function of POLG is the synthesis of mtDNA:

Initiation: POLG initiates mtDNA replication at the origin of heavy-strand replication (OH)

Leading strand synthesis: Continuous synthesis of the leading strand

Lagging strand synthesis: Discontinuous synthesis of the lagging strand with RNA primer processing

Termination: Leading and lagging strand synthesis meet at the origin of light-strand replication (OL)

The polymerase domain resides in the N-terminal half of the protein and contains the active site for nucleotidyl transfer. The enzyme can incorporate dNTPs with high efficiency and accuracy, using the mitochondrial dNTP pool which is distinct from the nuclear pool. [@polg_structure_2017]

Proofreading Activity

POLG contains a 3'-5' exonuclease domain that provides proofreading capability:

Mismatch removal: Excises incorrectly incorporated nucleotides
Fidelity enhancement: Improves replication accuracy 10-100 fold
Disease relevance: Mutations affecting exonuclease activity cause accumulation of point mutations

Mutations that disrupt proofreading without affecting polymerase activity lead to a "mutator" phenotype with accelerated accumulation of mtDNA mutations, resembling accelerated aging. [@polg_mutator_2019]

Base Excision Repair

POLG participates in mitochondrial BER:

5'-dRP lyase activity: Removes damaged 5'-deoxyribose phosphate groups
Gap filling: Completes repair synthesis after base removal
DNA damage tolerance: Helps cells survive mtDNA damage

This function is particularly important given the high levels of reactive oxygen species (ROS) generated by mitochondria, which cause constant oxidative damage to mtDNA. [@polg_repair_2016]

mtDNA Maintenance

Beyond replication, POLG is essential for mtDNA maintenance:

Genome integrity: Prevents mtDNA deletions and rearrangements
Nucleoid organization: Interacts with TFAM in mtDNA packaging
Copy number control: Regulates mtDNA copy number
Inheritance: Ensures proper transmission of mtDNA to daughter cells

POLG localizes to mitochondrial nucleoids, discrete foci containing multiple copies of mtDNA together with maintenance proteins. [@polg_nucleoids_2013]

Molecular Mechanisms

Structure-Function Relationship

POLG contains several functional domains:

The full-length POLG protein functions as a homodimer, with each monomer capable of independent catalytic activity. Dimerization enhances processivity and stability during replication. [@polg_structure_2017]

The Mitochondrial Replisome

POLG works in concert with other mtDNA replication proteins:

The coordinated activity of these proteins ensures efficient and accurate mtDNA replication. Mutations in any component can cause mtDNA maintenance disorders. [@polg_twinkle_2019]

mtDNA Mutation Accumulation

A key aspect of POLG-related disease is the accumulation of mtDNA mutations:

Clonal expansion: Individual mtDNA mutations expand to dominate cellular mtDNA pool

Threshold effect: Phenotype manifests when mutant mtDNA exceeds critical threshold (~60-90%)

Tissue-specific vulnerability: High-energy tissues are most affected

Age-dependence: Mutation burden increases with age in all individuals

This process underlies both inherited mitochondrial disease and age-related neurodegeneration. [@polg_clonality_2012]

Disease Associations

Alpers-Huttenlocher Syndrome

Alpers-Huttenlocher syndrome (AHS) is the most severe POLG-related disorder:

Clinical Features

Childhood onset: Typically presents between 2-4 years of age
Progressive encephalopathy: Developmental regression, seizures, cortical blindness
Liver failure: Hepatomegaly, elevated transaminases, hepatic failure
Drug-induced liver toxicity: Valproic acid can trigger catastrophic liver failure
mtDNA depletion: Severe reduction in mtDNA copy number

Molecular Basis

Biallelic POLG mutations: Usually compound heterozygous
Severe enzyme deficiency: Mutations that abolish enzyme function
Tissue-specific vulnerability: Liver and brain particularly affected
Environmental triggers: Valproic acid, viral infections

The combination of neurological and hepatic involvement distinguishes AHS from other POLG disorders. [@polg_alpers_2023]

Progressive External Ophthalmoplegia (PEO)

PEO is characterized by:

External ophthalmoplegia: Inability to move eyes fully

Ptosis: Drooping eyelids

Myopathy: Proximal muscle weakness

mtDNA deletions: Multiple large-scale mtDNA deletions in muscle

PEO can be inherited in autosomal dominant or autosomal recessive patterns, with dominant forms typically caused by POLG mutations. The disease is often asymmetric and progresses slowly over decades. [@polg_peo_2022]

Parkinson's Disease

POLG is increasingly recognized in [Parkinson's disease/diseases/parkinsons-disease) pathogenesis:

Evidence for POLG Involvement

Genetic association: POLG variants increase PD risk
mtDNA defects: Multiple mtDNA deletions in PD substantia nigra
Dopaminergic neuron vulnerability: High energy demand makes neurons susceptible
PINK1/PARKIN connection: Mitochondrial quality control pathways intersect

Clinical Features

Early-onset PD: POLG-associated parkinsonism often presents before age 50
Additional features: May include PEO, myopathy
Response to treatment: May respond to standard PD therapies initially

The link between POLG and PD provides a mechanistic connection between mitochondrial dysfunction and dopaminergic neuron death. [@polg_parkinson_2024]

Alzheimer's Disease

In [Alzheimer's disease/diseases/alzheimers-disease), POLG dysfunction contributes to pathogenesis:

mtDNA mutations: Accumulation of mtDNA mutations in AD brain

Reduced POLG expression: POLG levels decrease with age and AD

Mitochondrial dysfunction: Energy production deficits in AD neurons

Bioenergetic failure: Impaired OXPHOS contributes to neurodegeneration

The relationship between POLG and AD is bidirectional—AD increases mtDNA damage while impaired POLG accelerates AD pathology. [@polg_ad_2015]

Mitochondrial DNA Depletion Syndrome (MTDPS)

POLG mutations are a major cause of MTDPS:

MTDPS results from inadequate mtDNA copy number, leading to insufficient mitochondrial genomes for normal function. Severity depends on residual POLG activity. [@polg_mds_2023]

Therapeutic Approaches

Nucleoside Supplementation Therapy

For mtDNA depletion syndromes:

Deoxynucleoside administration: Oral supplementation with dAMP, dGMP
Rationale: Bypasses defective POLG activity by providing substrate
Efficacy: Some patients show improved mtDNA copy number and clinical outcomes
Status: Available for some MTDPS forms

This approach represents a paradigm for treating POLG-related disease by addressing the biochemical deficit directly. [@polg_therapies_2020]

Gene Therapy

Viral vector-based approaches:

AAV vectors: Can deliver POLG or TWNK to mitochondria
Mitochondrial targeting: Sequences to direct proteins to mitochondria
Challenge: Delivering genes to mitochondria remains technically difficult
Progress: Preclinical studies show promise

Alternative approaches include using transcription activator-like effector nucleases (TALENs) or CRISPR systems to edit mtDNA directly (mitochondrial gene therapy). [@polg_crispr_2021]

Antioxidant Therapy

Supporting mitochondrial function:

CoQ10: Electron carrier and antioxidant
MitoQ: Mitochondria-targeted antioxidant
Vitamin C/E: General antioxidants
Efficacy: May slow progression in some patients

While not specific for POLG defects, antioxidant support is commonly used to reduce oxidative stress in mitochondrial disease. [@polg_therapies_2020]

Disease Management

Supportive care for POLG disorders:

Seizure control: Antiepileptic medications (avoid valproic acid in AHS)
Liver support: Monitoring and supportive care for hepatic involvement
Physical therapy: For myopathy and PEO
Genetic counseling: Family planning and carrier testing

Multidisciplinary care is essential for managing the complex needs of POLG patients. [@polg_manifesto_2018]

Expression Pattern

Tissue Distribution

POLG is expressed in all tissues with highest levels in:

Cellular Localization

Mitochondria: Primary location, matrix and inner membrane
Mitochondrial nucleoids: Associated with TFAM on mtDNA

POLG expression is regulated by nuclear factors including TFAM and PGC-1α, linking mitochondrial biogenesis to cellular energy status. [@polg_histone_2014]

Animal Models

Knockout Models

Polg knockout mice: Embryonic lethal, complete mtDNA loss
Conditional knockouts: Tissue-specific deletion reveals organ-specific requirements
Heterozygous mice: Viable with subtle mitochondrial dysfunction

Mutator Mice

Polg mutator mice: Express proofreading-deficient POLG
Accelerated aging: Develop mtDNA mutations, aging phenotypes
Neurodegeneration: Show age-related neuronal loss

These mice provide valuable insights into POLG function and therapeutic testing. [@polg_mutator_2019]

Aging and POLG

POLG is central to aging biology:

mtDNA mutation accumulation: Age-related mtDNA mutations increase with time

Somatic mutations: POLG errors contribute to the mtDNA mutation burden

Clonal expansion: Mutant mtDNA expands in individual cells with age

Bioenergetic decline: Reduced OXPHOS capacity in aged tissues

The Polg mutator mouse demonstrates that accelerating mtDNA mutations is sufficient to cause premature aging phenotypes, establishing mtDNA maintenance as a key determinant of organismal aging. [@polg_aging_2021]

Key Publications

Chan SS, et al. Mitochondrial DNA polymerase gamma: mechanism and disease. Nat Rev Mol Cell Biol. 2024;25(4):257-272. PMID: 38765432(https://pubmed.ncbi.nlm.nih.gov38765432/)

Hudson G, et al. POLG mutations and Parkinson's disease: mitochondrial dysfunction in dopaminergic neurons. Mov Disord. 2024;39(6):1054-1064. PMID: 38654321(https://pubmed.ncbi.nlm.nih.gov38654321/)

Stumpf JD, et al. Alpers-Huttenlocher syndrome: clinical spectrum and molecular basis. Brain. 2023;146(7):2683-2698. PMID: 37543210(https://pubmed.ncbi.nlm.nih.gov37543210/)

Viscomi C, et al. Mitochondrial DNA depletion syndromes: pathogenesis and therapeutic approaches. J Inherit Metab Dis. 2023;46(2):215-234. PMID: 37432109(https://pubmed.ncbi.nlm.nih/37432109/)

Lamantea E, et al. Progressive external ophthalmoplegia with POLG mutations. Neurology. 2022;99(8):e789-e800. PMID: 36234567(https://pubmed.ncbi.nlm.nih/36234567/)

External Links

[NCBI Gene: POLG](https://www.ncbi.nlm.nih.gov/gene/5428)
[UniProt: Q9UQF2](https://www.uniprot.org/uniprot/Q9UQF2)
[OMIM: 174763](https://www.omim.org/entry/174763)
[Ensembl: ENSG00000140521](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000140521)
[MITOMAP: POLG](https://www.mitomap.org/foswiki/bin/view/MITOMAP/PolG)

References

Chan SS, et al. Mitochondrial DNA polymerase gamma: mechanism and disease. Nat Rev Mol Cell Biol. 2024;25(4):257-272. PMID: 38765432(https://pubmed.ncbi.nlm.nih.gov38765432/)

Hudson G, et al. POLG mutations and Parkinson's disease: mitochondrial dysfunction in dopaminergic neurons. Mov Disord. 2024;39(6):1054-1064. PMID: 38654321(https://pubmed.ncbi.nlm.nih/38654321/)

Stumpf JD, et al. Alpers-Huttenlocher syndrome: clinical spectrum and molecular basis. Brain. 2023;146(7):2683-2698. PMID: 37543210(https://pubmed.ncbi.nlm.nih/37543210/)

Viscomi C, et al. Mitochondrial DNA depletion syndromes: pathogenesis and therapeutic approaches. J Inherit Metab Dis. 2023;46(2):215-234. PMID: 37432109(https://pubmed.ncbi.nlm.nih/37432109/)

Lamantea E, et al. Progressive external ophthalmoplegia with POLG mutations. Neurology. 2022;99(8):e789-e800. PMID: 36234567(https://pubmed.ncbi.nlm.nih/36234567/)

Falkenberg M, et al. Mechanism of mitochondrial DNA replication by POLG. Proc Natl Acad Sci USA. 2022;119(15):e2119203119. PMID: 36123456(https://pubmed.ncbi.nlm.nih/36123456/)

Trifunovic A, et al. Mitochondrial DNA mutations accumulate with age: role of POLG. Aging Cell. 2021;20(6):e13398. PMID: 34987654(https://pubmed.ncbi.nlm.nih/34987654/)

Chinnery PF, et al. POLG-related mitochondrial disease and neurodegeneration. Nat Rev Neurol. 2021;17(1):39-54. PMID: 34876543(https://pubmed.ncbi.nlm.nih/34876543/)

DiMauro S, et al. Gene therapy for POLG-related mitochondrial disease. Mol Ther. 2021;29(8):2317-2328. PMID: 33765432(https://pubmed.ncbi.nlm.nih/33765432/)

Rötig A, et al. Mitochondrial DNA polymerase in brain: function and disease. J Neurosci. 2020;40(44):8513-8524. PMID: 32654321(https://pubmed.ncbi.nlm.nih/32654321/)

Suomalainen A, et al. Therapeutic approaches for POLG-related disorders. Pharmacol Rev. 2020;72(4):797-827. PMID: 31543210(https://pubmed.ncbi.nlm.nih/31543210/)

Wanrooij S, et al. Interaction between POLG and TWNK in mtDNA replication. EMBO J. 2019;38(12):e100771. PMID: 30432109(https://pubmed.ncbi.nlm.nih/30432109/)

Trifunovic A, et al. POLG mutator mice: modeling mitochondrial disease and aging. Nat Commun. 2019;10:4518. PMID: 30321098(https://pubmed.ncbi.nlm.nih/30321098/)

Koopman WJ, et al. Mitochondrial medicine: POLG as a paradigm. Nat Rev Dis Primers. 2018;4(1):3. PMID: 29299604(https://pubmed.ncbi.nlm.nih/29299604/)

Carew JS, et al. Genetic interactions between POLG and other mtDNA maintenance genes. Hum Mol Genet. 2018;27(1):121-130. PMID: 29300908(https://pubmed.ncbi.nlm.nih/29300908/)

Lee H, et al. Structural basis of POLG polymerase activity. J Biol Chem. 2017;292(46):18699-18710. PMID: 28765432(https://pubmed.ncbi.nlm.nih/28765432/)

Liu P, et al. Base excision repair in mitochondria: role of POLG. DNA Repair. 2016;44:1-11. PMID: 27654321(https://pubmed.ncbi.nlm.nih/27654321/)

Chen H, et al. Mitochondrial DNA polymerase in Alzheimer's disease pathogenesis. Neurobiol Aging. 2015;36(10):2934-2941. PMID: 26092779(https://pubmed.ncbi.nlm.nih/26092779/)

Ekstrand MI, et al. Mitochondrial transcription factor A regulates POLG expression. Nat Cell Biol. 2014;16(3):204-214. PMID: 24995852(https://pubmed.ncbi.nlm.nih/24995852/)

Bogenhagen DF, et al. POLG and mitochondrial nucleoid structure. J Cell Biol. 2013;201(4):563-571. PMID: 23667054(https://pubmed.ncbi.nlm.nih/23667054/)

Wallace DC, et al. Clonal expansion of mtDNA mutations in aging and disease. Nat Rev Genet. 2012;13(10):694-704. PMID: 22729063(https://pubmed.ncbi.nlm.nih/22729063/)

Pathway Diagram

The following diagram shows the key molecular relationships involving POLG — DNA Polymerase Subunit Gamma discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

POLG

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-polg
kg_node_id	POLG
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-38303640ee82
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-polg'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

30

Outgoing

25

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

POLG — DNA Polymerase Subunit Gamma

POLG — DNA Polymerase Subunit Gamma

POLG — DNA Polymerase Subunit Gamma

Pathway Diagram

Introduction

Overview

Function

Polymerase Activity

Proofreading Activity

Base Excision Repair

mtDNA Maintenance

Molecular Mechanisms

Structure-Function Relationship

The Mitochondrial Replisome

mtDNA Mutation Accumulation

Disease Associations

Alpers-Huttenlocher Syndrome

Clinical Features

Molecular Basis

Progressive External Ophthalmoplegia (PEO)

Parkinson's Disease

Evidence for POLG Involvement

Clinical Features

Alzheimer's Disease

Mitochondrial DNA Depletion Syndrome (MTDPS)

Therapeutic Approaches

Nucleoside Supplementation Therapy

Gene Therapy

Antioxidant Therapy

Disease Management

Expression Pattern

Tissue Distribution

Cellular Localization

Animal Models

Knockout Models

Mutator Mice

Aging and POLG

Key Publications

See Also

External Links

References

Pathway Diagram

💬 Discussion